Search results
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoOverall, Pfizer's SWOT analysis reveals a company with the resources and capabilities to adapt and thrive in a dynamic industry landscape....
Pfizer Inc's Dividend Analysis
Guru Focus· 4 days agoPfizer Inc (PFE, Financial) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors look forward ...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
Swiss National Bank Decreases Holdings in Iron Mountain Incorporated (NYSE:IRM)
ETF DAILY NEWS· 7 days agoSwiss National Bank decreased its position in Iron Mountain Incorporated (NYSE:IRM – Free Report) by...
Commonwealth Equity Services LLC Raises Stock Position in Aflac Incorporated (NYSE:AFL)
ETF DAILY NEWS· 7 days agoCommonwealth Equity Services LLC boosted its position in shares of Aflac Incorporated (NYSE:AFL –...
BioRestorative Therapies (BRTX) & Its Competitors Financial Analysis
ETF DAILY NEWS· 7 days agoBioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) is one of 425 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare BioRestorative ...
DEI is getting a new name. Can it dump the political baggage?
New Hampshire Union Leader· 2 days agoLast year, Eli Lilly’s annual shareholders letter referenced the acronym for diversity, equity and...
S&P 500's Best 3-Day Run in 2024: ETF Areas That Won
Zacks via Yahoo Finance· 5 days agoGarmin Ltd. GRMN has about 7.29% exposure to SNSR. Garmin is an original equipment manufacturer of navigation and communication equipment that ...
About 79% of the S&P 500 names beat on EPS this week - Earnings
Seeking Alpha· 7 days agoA recap of the first quarter earnings week on Wall Street, highlighting the performances of big...
Corcept Therapeutics (NASDAQ:CORT) Downgraded by StockNews.com
ETF DAILY NEWS· 7 days agoTruist Financial increased their price objective on shares of Corcept Therapeutics from $42.00 to $44.00 and gave the company a buy rating in a research report on Thursday. HC Wainwright increased ...